Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity - two common nerve agents
Stock Information for Nexien BioPharma Inc
Loading
Please wait while we load your information from QuoteMedia.